SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $438,599,158 |
| Positions | 147 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| INVESCO DB COMMDY INDX TRCK | DBC | UNIT | $28,185,965 | 1,057,238 |
| ABIVAX SA | ABVX | SPONSORED ADS | $15,062,511 | 113,031 |
| REVOLUTION MEDICINES INC | RVMD | COM | $12,544,576 | 66,983 |
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $11,425,263 | 242,884 |
| IMMUNOVANT INC | IMVT | COM | $10,706,447 | 277,873 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $10,114,006 | 30,210 |
| RELAY THERAPEUTICS INC | RLAY | COM | $9,471,675 | 506,235 |
| ALKERMES PLC | ALKS | SHS | $9,392,118 | 179,256 |
| VAXCYTE INC | PCVX | COM | $8,704,329 | 149,739 |
| TANGO THERAPEUTICS INC | TNGX | COM | $8,129,788 | 260,070 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.